CF Foundation invests in breath test to detect Pseudomonas
The Cystic Fibrosis Foundation will invest up to $2.3 million for a company to develop a breath test designed to detect Pseudomonas aeruginosa and to monitor chronic infections in people with cystic fibrosis (CF). P. aeruginosa bacteria are a major cause of lung disease in people with CF. Although…